These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway. Sasai M; Tatematsu M; Oshiumi H; Funami K; Matsumoto M; Hatakeyama S; Seya T Mol Immunol; 2010 Mar; 47(6):1283-91. PubMed ID: 20047764 [TBL] [Abstract][Full Text] [Related]
3. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like. Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750 [TBL] [Abstract][Full Text] [Related]
4. Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction. Takaki H; Oshiumi H; Sasai M; Kawanishi T; Matsumoto M; Seya T Eur J Immunol; 2009 Dec; 39(12):3469-76. PubMed ID: 19795416 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene. Hardy MP; McGGettrick AF; O'Neill LA Biochem J; 2004 May; 380(Pt 1):83-93. PubMed ID: 14960149 [TBL] [Abstract][Full Text] [Related]
6. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262 [TBL] [Abstract][Full Text] [Related]
7. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. An H; Zhao W; Hou J; Zhang Y; Xie Y; Zheng Y; Xu H; Qian C; Zhou J; Yu Y; Liu S; Feng G; Cao X Immunity; 2006 Dec; 25(6):919-28. PubMed ID: 17157040 [TBL] [Abstract][Full Text] [Related]
8. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043 [TBL] [Abstract][Full Text] [Related]
9. TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15. Ahmed S; Maratha A; Butt AQ; Shevlin E; Miggin SM J Immunol; 2013 Mar; 190(5):2217-28. PubMed ID: 23365087 [TBL] [Abstract][Full Text] [Related]
10. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100 [TBL] [Abstract][Full Text] [Related]
11. TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. Takeshita F; Ishii KJ; Kobiyama K; Kojima Y; Coban C; Sasaki S; Ishii N; Klinman DM; Okuda K; Akira S; Suzuki K Eur J Immunol; 2005 Aug; 35(8):2477-85. PubMed ID: 16052631 [TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Jiang Z; Mak TW; Sen G; Li X Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987 [TBL] [Abstract][Full Text] [Related]
13. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta. Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359 [TBL] [Abstract][Full Text] [Related]
14. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061 [TBL] [Abstract][Full Text] [Related]
15. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355 [TBL] [Abstract][Full Text] [Related]
16. TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin. Park SJ; Lee AN; Youn HS Arch Pharm Res; 2010 Jun; 33(6):939-45. PubMed ID: 20607500 [TBL] [Abstract][Full Text] [Related]
17. PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis. Zhang J; Xu LG; Han KJ; Wei X; Shu HB FEBS Lett; 2004 Jul; 570(1-3):97-101. PubMed ID: 15251447 [TBL] [Abstract][Full Text] [Related]
18. Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing. Seya T; Matsumoto M; Ebihara T; Oshiumi H Immunol Rev; 2009 Jan; 227(1):44-53. PubMed ID: 19120474 [TBL] [Abstract][Full Text] [Related]
19. SARM inhibits both TRIF- and MyD88-mediated AP-1 activation. Peng J; Yuan Q; Lin B; Panneerselvam P; Wang X; Luan XL; Lim SK; Leung BP; Ho B; Ding JL Eur J Immunol; 2010 Jun; 40(6):1738-47. PubMed ID: 20306472 [TBL] [Abstract][Full Text] [Related]